Pattern Bioscience Funding & Investors
Austin, TX
Pattern Bioscience is a privately held in vitro diagnostics company founded in 2016 to help combat the problem of antibiotic resistance. Pattern is developing a next-generation clinical microbiology platform based on its patented phenotypic single-cell technology that can rapidly identify pathogens and determine their antibiotic response without the need for traditional time-consuming culture steps. Pattern’s Digital CultureTM technology relies on functional endpoints that encompass all possible resistance mechanisms, resulting in a more comprehensive and reliable diagnosis compared to rapid genotypic tests. The platform will deliver more reliable diagnoses days faster than the current standard of care.
pattern.bioTotal Amount Raised:
Pattern Bioscience Funding Rounds
Pre Seed
120,000 GBP
Pre Seed Investors
AntlerSeries C
$28,700,000
Series C Investors
Illumina VenturesOmnimed CapitalDaleshawAntimicrobial resistanceSeries C
$28,700,000
Series C Investors
Illumina VenturesOmnimed CapitalDaleshawAntimicrobial resistanceSeries B
$9,000,000
Series B Investors
Illumina VenturesOmninet CapitalSeries B
$9,000,000
Series B Investors
Illumina VenturesOmninet CapitalSeries B
$6,400,000
Series B Investors
Omnimed CapitalGrant
$6,800,000
Grant Investors
CARB-XGrant
$6,800,000
Grant Investors
CARB-XSeries A
$3,750,000
Series A Investors
Omnimed Capital